Ultragenyx Pharmaceutical Inc. buy stratec
Start price
08.12.17
/
50%
€42.20
Target price
01.01.19
€82.98
Performance (%)
-7.05%
End price
01.01.19
€39.22
Summary
This prediction ended on 01.01.19 with a price of €39.22. With a performance of -7.05%, the BUY prediction by stratec finished with a loss. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.282% | -1.282% | -29.032% | -27.014% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% | 65.292% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% | 97.467% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% | 39.755% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% | 61.093% |
Comments by stratec for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
stratec stimmt der Outperform-Einschätzung der institutionellen Analysten zu
stratec stimmt am 08.12.2017 der Outperform-Einschätzung der institutionellen Analysten, aber mit dem Kursziel von 72 $ zu.
(Laufzeit überschritten)